It advises against using the product which has no medicinal effect
Behav Brain Res 167:212218 Sideri A, Bakirtzi K, Shih DQ, Koon HW, Fleshner P, Arsenescu R, Arsenescu V, Turner JR, Karagiannides I, Pothoulakis C (2015) Substance-P mediates pro-inflammatory cytokine release form mesenteric adipocytes in inflammatory bowel disease patients
This guide explains what retatrutide is, how its triple-receptor mechanism works, who it is being studied for, the trial results and side effects reported so far, how it compares to semaglutide and tirzepatide, and where it stands in the FDA approval process
Never discontinue semaglutide without medical guidance, as abrupt cessation can affect glycemic control in diabetes patients